KURA Kura Oncology, Inc.

$11.39▼ -1.56% Healthcare Other
After hours $11.44▲ +0.44% Sep 11, 7:40 PM ET
Volume 2.12M Avg Volume (10D) 1.79M
Key Metrics & Fundamentals
Market Cap
$1.01B
P/E Ratio
–
Div Yield
–%
52W Range
7.36 - 13.90
% vs 50 MA
1.82%
% vs 200 MA
15.95%
RSI-14
44.8
MACD Histogram
-0.2200
Beta (1Y vs SPY)
1.41
Free Cash Flow
-$63.21M
Gross Rev
$20.87M
Gross Profit
$20.63M
EBITDA
-$67.61M
COGS
$243,000
Operating Exp
$93.64M
Operating Income
-$73.01M
EBIT
-$73.01M
Pretax Income
-$68.32M
Net Income
-$68.33M
EPS (Diluted)
-0.77
Price & Volume History
Loading chart…
Recent News
Kura Oncology Pivots Diabetes Strategy Into $50 Million Subsidiary
Benzinga · Sep 9, 2026 1:57 PM
Kura spins diabetes work into a Lilly-backed biotech startup
BioPharma Dive · Sep 9, 2026 11:54 AM
Kura Oncology Launches Caspian Therapeutics With $50 Million Funding
MT Newswires · Sep 9, 2026 11:44 AM
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes
GlobeNewswire · Sep 9, 2026 11:00 AM
Kura Oncology Names Jennifer Fulk Finance Chief
MT Newswires · Sep 8, 2026 12:05 PM
Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer
GlobeNewswire · Sep 8, 2026 11:00 AM
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 4, 2026 11:30 AM
Kura Oncology (KURA) Stock Looks Fully Priced After Its 56% Run
Simply Wall St. · Sep 2, 2026 11:06 PM
KURA Stock Gains 37.6% in a Month: Here's What You Need to Know
Zacks · Sep 1, 2026 1:05 PM
Kura Oncology to Participate in Three Investor Conferences in September
GlobeNewswire · Sep 1, 2026 11:15 AM
Financial Overview - Income Statement Quarterly

See KURA's money flow as a full page

Social Sentiment
Avg +0.60 · 2 posts
TradeDiscussionThis Sushi stock is rolling along the Bollinger Bands like a pro
r/StockMarket · Jun 26, 2025
The post refers to KURA as a stock being analyzed for swing trading.
positive +0.60
NewsDiscussionTradePriceTargetKURA Oncology YOLO
r/wallstreetbets · Nov 24, 2024
The author expresses a bullish outlook and anticipates a potential price run-up, driven by a partnership agreement and upcoming conference.
positive +0.60
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙